A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong ...
For years, treatment of older patients with acute myeloid leukemia—an aggressive cancer of the blood and bone marrow—has ...
Patients with acute leukemia prioritize tiredness as the most important health dimension over cognition, differing from the general public's preferences. Informal caregivers report significant ...
Acute leukemia is a group of hematologic malignancies categorized according to the immature cells that proliferate and replace the normal bone marrow. Flow cytometry has emerged as a cornerstone in ...
The BD OneFlow™ AML/MDS Panel is intended for qualitative flow-cytometric immunophenotyping of mature and immature hematopoietic cells populations (lymphoid and myeloid lineages) in bone marrow and ...
So now, you know, we have competing standards of care in the frontline for AML, which is either high intensity induction or ...
The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...
Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results